VYNE Therapeutics Inc (VYNE)

2.39 +0.09 (+3.91%) USD  |  NASDAQ  |  Jun 17, 14:28
More

VYNE Therapeutics EPS Estimates for Current Quarter

EPS Estimates for Current Quarter Chart

View EPS Estimates for Current Quarter for VYNE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS Estimates for Current Quarter Data

View and export this data back to 2022. Upgrade now.
Date Value
August 14, 2023 --
Date Value
May 12, 2022 --

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for Current Quarter Range, Past 5 Years

Upgrade
Minimum
May 12 2022
Upgrade
Maximum
Aug 14 2023
Upgrade
Average
Upgrade
Median

EPS Estimates for Current Quarter Benchmarks

Geron Corp Upgrade
NovaBay Pharmaceuticals Inc Upgrade
Palatin Technologies Inc Upgrade
iBio Inc Upgrade
Theriva Biologics Inc Upgrade

EPS Estimates for Current Quarter Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade